-
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US45824Q5071 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Target Price | None |
|---|---|
| Beta | -0.14 |
| Market Cap | 4M |
| PE Ratio | None |
| Dividend Yield | None |
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain through a small sensor clipped onto the earlobe. It also develops the GlucoTrack CBGM, a long-term implantable CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for GCTK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025